1. Clinical Overview
Clotrimazole is a broad-spectrum synthetic imidazole antifungal agent used primarily as a vaginal pessary for the local treatment of vulvovaginal candidiasis (VVC). It acts by inhibiting ergosterol synthesis, a critical component of fungal cell membranes, leading to increased membrane permeability and cell death. The 200mg vaginal pessary is a standard, short-course therapy for uncomplicated VVC in the Indian setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| Symptomatic relief (itching, burning) often begins within 24-72 hours of administration. | Therapeutic effect persists for several days post-administration. A single 200mg pessary is typically sufficient for a full course of treatment for uncomplicated VVC. | Negligible systemic absorption (<0.5%) following intravaginal administration. Primarily acts locally. |
2. Mechanism of Action
Clotrimazole is a fungistatic and fungicidal agent. It inhibits the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This inhibition blocks the conversion of lanosterol to ergosterol, an essential sterol component of the fungal cell membrane. Depletion of ergosterol and accumulation of toxic methylated sterols disrupts membrane structure and function, increasing permeability and leading to leakage of cellular contents and eventual cell death.
3. Indications & Uses
- Vulvovaginal Candidiasis (VVC) - Uncomplicated
- Vaginal yeast infections
4. Dosage & Administration
Adult Dosage: For uncomplicated VVC: One 200mg vaginal pessary inserted intravaginally at bedtime, as a single dose. Alternatively, 100mg once daily for 3 nights or 500mg as a single dose (depending on formulation).
Administration: 1. Wash hands before and after use. 2. Insert the pessary high into the vagina using the applicator or finger, preferably at bedtime. 3. Use a sanitary pad to protect clothing from leakage (the pessary base melts). 4. Complete the full course even if symptoms improve. 5. Avoid tampons, douches, or other vaginal products during treatment. 6. Refrain from sexual intercourse during treatment or use a condom to prevent re-infection/irritation.
5. Side Effects
Common side effects may include:
- Mild vaginal burning/itching immediately after insertion
- Vaginal irritation
- Mild abdominal cramps
- Headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Amphotericin B, Nystatin | Potential antagonistic antifungal effect; concurrent use not recommended. | Moderate |
| CYP3A4 substrates (e.g., Cyclosporine, Tacrolimus) | Theoretical interaction due to systemic absorption; unlikely with vaginal use but monitor if signs of toxicity appear. | Low |
| Vaginal spermicides (e.g., Nonoxynol-9) | May cause increased vaginal irritation. Avoid concurrent use. | Moderate |
7. Patient Counselling
- DO complete the full treatment even if symptoms improve early.
- DO insert the pessary at bedtime for best retention.
- DO wear cotton underwear and loose-fitting clothing.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DONT use tampons, douches, or vaginal deodorants during treatment.
- DONT engage in sexual intercourse during treatment unless using a condom.
- DONT stop treatment during menstruation; continue the course.
8. Toxicology & Storage
Overdose: Acute overdose via vaginal route is unlikely to cause systemic toxicity. Symptoms would be limited to local irritation, burning, and possibly allergic reactions.
Storage: Store below 25°C, in a cool, dry place. Protect from light and moisture. Keep out of reach of children. Do not use if the foil strip is torn or damaged.